Cargando…

Alzheimer's Disease with Vascular Component: A Distinct Clinical Entity?

BACKGROUND: Longitudinal reports on the clinical features of patients with Alzheimer's disease (AD) and concomitant cerebrovascular disease are scarce. METHODS: We elaborated a working definition of AD with vascular component (ADVC), and this definition was retrospectively investigated in a coh...

Descripción completa

Detalles Bibliográficos
Autores principales:	Olazarán, Javier, Navarro, Eloísa, Rojo, José Manuel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2012
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493007/ https://www.ncbi.nlm.nih.gov/pubmed/23139685 http://dx.doi.org/10.1159/000342346

Ejemplares similares

Persistence of Cholinesterase Inhibitor Treatment in Dementia: Insights from a Naturalistic Study
por: Olazarán, Javier, et al.
Publicado: (2013)

Poikiloderma Vasculare Atrophicans: A Distinct Clinical Entity?
por: Mahajan, Vikram K, et al.
Publicado: (2015)

Predescemetocele: A distinct clinical entity
por: Narang, Priya, et al.
Publicado: (2017)

A Review on Tramiprosate (Homotaurine) in Alzheimer's Disease and Other Neurocognitive Disorders
por: Manzano, Sagrario, et al.
Publicado: (2020)

‘Obesities’: Position statement on a complex disease entity with multifaceted drivers
por: Yárnoz‐Esquiroz, Patricia, et al.
Publicado: (2022)

Revisiting a Distinct Entity in Pulmonary Vascular Disease: Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
por: Sharma, Munish, et al.
Publicado: (2021)

Is Chronic Mania a Distinct Clinical Entity?
por: Singh, Gurvinder Pal, et al.
Publicado: (2011)

Depression in Alzheimer's Disease: A Delphi Consensus on Etiology, Risk Factors, and Clinical Management
por: Agüera-Ortiz, Luis, et al.
Publicado: (2021)

Mild cognitive impairment in Parkinson’s disease: a distinct clinical entity?
por: Wen, Ming-Ching, et al.
Publicado: (2017)

Is the distinction between Alzheimer's disease and vascular dementia possible and relevant?
por: Ravona-Springer, Ramit, et al.
Publicado: (2003)

Combining entity co-occurrence with specialized word embeddings to measure entity relation in Alzheimer’s disease
por: Heo, Go Eun, et al.
Publicado: (2019)

Distinct effects of cholesterol profile components on amyloid and vascular burdens
por: Kang, Sung Hoon, et al.
Publicado: (2023)

X-linked intellectual disability type Nascimento is a clinically distinct, probably underdiagnosed entity
por: Czeschik, Johanna Christina, et al.
Publicado: (2013)

Secondary acute lymphoblastic leukemia is a distinct clinical entity with prognostic significance
por: Rosenberg, A S, et al.
Publicado: (2017)

Fungal bronchitis is a distinct clinical entity which is responsive to antifungal therapy
por: Ozyigit, Leyla Pur, et al.
Publicado: (2021)

Porto-Sinusoidal Vascular Disease Associated to Oxaliplatin: An Entity to Think about It
por: Puente, Angela, et al.
Publicado: (2019)

Penoscrotal porokeratosis: A distinct entity
por: Joshi, Rajiv, et al.
Publicado: (2015)

Is the Cerebellum the Optimal Reference Region for Intensity Normalization of Perfusion MR Studies in Early Alzheimer’s Disease?
por: Lacalle-Aurioles, María, et al.
Publicado: (2013)

Multiple Drug Intolerance Syndrome: An Underreported Distinct Clinical Entity
por: Behera, Sapan K., et al.
Publicado: (2019)

Taxonomic reclassification of Kaposi Sarcoma identifies disease entities with distinct immunopathogenesis
por: Openshaw, M. R., et al.
Publicado: (2023)

Irritable Inflammatory Bowel Syndrome as a Distinct Disease Entity
por: Oh, Jung Hwan
Publicado: (2016)

Chronic thromboembolic pulmonary hypertension: a distinct disease entity
por: Lang, Irene
Publicado: (2015)

Mucoepidermoid Carcinoma of Uterine Cervix: A Distinct Pathological and Clinical Entity
por: Selcuk, Ilker, et al.
Publicado: (2015)

Primary Larynx Cryptococcus neoformans Infection: A Distinctive Clinical Entity
por: Bergeron, Mathieu, et al.
Publicado: (2015)

Inflammatory Breast Cancer: A Distinct Clinicopathological Entity Transcending Histological Distinction
por: Raghav, K., et al.
Publicado: (2016)

Subpopulations of Staphylococcus aureus Clonal Complex 121 Are Associated with Distinct Clinical Entities
por: Kurt, Kevin, et al.
Publicado: (2013)

Is mucinous carcinoma of the colorectum a distinct genetic entity?
por: Hanski, C.
Publicado: (1995)

Severe COVID-19: A distinct entity
por: Garg, Ravindra Kumar, et al.
Publicado: (2021)

Pulmonary capillary haemangiomatosis: a distinct entity?
por: Weatherald, Jason, et al.
Publicado: (2020)

Acute Confusional Migraine: Distinct Clinical Entity or Spectrum of Migraine Biology?
por: Farooqi, Ashar M., et al.
Publicado: (2018)

Coronary Microvascular Dysfunction: Is It Distinct Clinical Entity or Common Physiologic Pathway?
por: Ahn, Jung-Min
Publicado: (2020)

Prevalence of treated patients with Alzheimer’s disease: current trends and COVID-19 impact
por: Olazarán, Javier, et al.
Publicado: (2023)

Calcifying nanoparticles: one face of distinct entities?
por: Kutikhin, Anton G., et al.
Publicado: (2014)

HTLV‐I Uveitis: A Distinct Clinical Entity Caused by HTLV‐I
por: Mochizuki, Manabu, et al.
Publicado: (1992)

Cochlear Meniere's: A Distinct Clinical Entity With Isolated Cochlear Hydrops on High-Resolution MRI?
por: Alonso, Jose E., et al.
Publicado: (2021)

Gene partners of the EWSR1 fusion may represent molecularly distinct entities
por: Walker, Victoria, et al.
Publicado: (2023)

Early onset esophageal adenocarcinoma: a distinct molecular entity?
por: van Nistelrooij, Anna M.J., et al.
Publicado: (2016)

Poor Performer: A Distinct Entity in Cochlear Implant Users?
por: Völter, Christiane, et al.
Publicado: (2022)

Tumors diagnosed as cerebellar glioblastoma comprise distinct molecular entities
por: Reinhardt, Annekathrin, et al.
Publicado: (2019)

Monoarticular juvenile idiopathic arthritis as a distinct clinical entity A proof-of-concept study
por: Zulian, Francesco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4neale153mm6u8p76i75ct3sj3